Collegium Pharmaceutical
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $188,000 | $177,757 | $181,949 | $159,301 |
Gross Profit | 108,384 | 97,324 | 98,288 | 96,794 |
EBITDA | 80,476 | 96,435 | 75,721 | |
EBIT | 23,912 | 39,923 | 33,974 | |
Net Income | 11,983 | 2,417 | 12,536 | 9,335 |
Net Change In Cash | 188,000 | 177,757 | 181,949 | 159,301 |
Free Cash Flow | 72,374 | 54,600 | 84,074 | -9,243 |
Cash | 117,348 | 96,192 | 70,565 | 38,960 |
Basic Shares | 31,549 | 32,840 | 40,109 | 40,163 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $631,449 | $566,767 | $463,933 | $276,868 |
Gross Profit | 377,344 | 326,169 | 209,488 | 150,617 |
EBITDA | 341,702 | 308,328 | 168,757 | 86,575 |
EBIT | 172,542 | 159,072 | 34,366 | 17,640 |
Net Income | 69,190 | 48,155 | -25,002 | 71,517 |
Net Change In Cash | 631,449 | 566,767 | 463,933 | 276,868 |
Cost of Revenue | -12,738 | 12,310 | ||
Free Cash Flow | 203,328 | 274,288 | 122,608 | 101,613 |
Cash | 70,565 | 238,947 | 173,688 | 186,426 |
Basic Shares | 40,424 | 41,788 | 33,829 | 41,045 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $1.68 |
2025-03-31 | $1.49 |
2024-12-31 | $1.77 |
